Dosimetry for nonuniform activity distributions: A method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations

A. C. Traino, S. Marcatili, C. Avigo, M. Sollini, P. A. Erba, G. Mariani

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: Nonuniform activity within the target lesions and the critical organs constitutes an important limitation for dosimetric estimates in patients treated with tumor-seeking radiopharmaceuticals. The tumor control probability and the normal tissue complication probability are affected by the distribution of the radionuclide in the treated organtissue. In this paper, a straightforward method for calculating the absorbed dose at the voxel level is described. This new method takes into account a nonuniform activity distribution in the targetorgan. Methods: The new method is based on the macroscopic S-values (i.e., the S-values calculated for the various organs, as defined in the MIRD approach), on the definition of the number of voxels, and on the raw-count 3D array, corrected for attenuation, scatter, and collimator resolution, in the lesionorgan considered. Starting from these parameters, the only mathematical operation required is to multiply the 3D array by a scalar value, thus avoiding all the complex operations involving the 3D arrays. Results: A comparison with the MIRD approach, fully described in the MIRD Pamphlet No. 17, using S-values at the voxel level, showed a good agreement between the two methods for 131I and for 90Y. Conclusions: Voxel dosimetry is becoming more and more important when performing therapy with tumor-seeking radiopharmaceuticals. The method presented here does not require calculating the S-values at the voxel level, and thus bypasses the mathematical problems linked to the convolution of 3D arrays and to the voxel size. In the paper, the results obtained with this new simplified method as well as the possibility of using it for other radionuclides commonly employed in therapy are discussed. The possibility of using the correct density value of the tissueorgans involved is also discussed.

Original languageEnglish
Article number042505
JournalMedical Physics
Volume40
Issue number4
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Radiopharmaceuticals
Radioisotopes
Neoplasms
Pamphlets
Therapeutics

Keywords

  • 3D dosimetry
  • internal dosimetry
  • Nuclear Medicine Therapy
  • voxel dosimetry

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Dosimetry for nonuniform activity distributions : A method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations. / Traino, A. C.; Marcatili, S.; Avigo, C.; Sollini, M.; Erba, P. A.; Mariani, G.

In: Medical Physics, Vol. 40, No. 4, 042505, 04.2013.

Research output: Contribution to journalArticle

@article{2025a48ed866439dac5d9458b6134805,
title = "Dosimetry for nonuniform activity distributions: A method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations",
abstract = "Purpose: Nonuniform activity within the target lesions and the critical organs constitutes an important limitation for dosimetric estimates in patients treated with tumor-seeking radiopharmaceuticals. The tumor control probability and the normal tissue complication probability are affected by the distribution of the radionuclide in the treated organtissue. In this paper, a straightforward method for calculating the absorbed dose at the voxel level is described. This new method takes into account a nonuniform activity distribution in the targetorgan. Methods: The new method is based on the macroscopic S-values (i.e., the S-values calculated for the various organs, as defined in the MIRD approach), on the definition of the number of voxels, and on the raw-count 3D array, corrected for attenuation, scatter, and collimator resolution, in the lesionorgan considered. Starting from these parameters, the only mathematical operation required is to multiply the 3D array by a scalar value, thus avoiding all the complex operations involving the 3D arrays. Results: A comparison with the MIRD approach, fully described in the MIRD Pamphlet No. 17, using S-values at the voxel level, showed a good agreement between the two methods for 131I and for 90Y. Conclusions: Voxel dosimetry is becoming more and more important when performing therapy with tumor-seeking radiopharmaceuticals. The method presented here does not require calculating the S-values at the voxel level, and thus bypasses the mathematical problems linked to the convolution of 3D arrays and to the voxel size. In the paper, the results obtained with this new simplified method as well as the possibility of using it for other radionuclides commonly employed in therapy are discussed. The possibility of using the correct density value of the tissueorgans involved is also discussed.",
keywords = "3D dosimetry, internal dosimetry, Nuclear Medicine Therapy, voxel dosimetry",
author = "Traino, {A. C.} and S. Marcatili and C. Avigo and M. Sollini and Erba, {P. A.} and G. Mariani",
year = "2013",
month = "4",
doi = "10.1118/1.4794473",
language = "English",
volume = "40",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Dosimetry for nonuniform activity distributions

T2 - A method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations

AU - Traino, A. C.

AU - Marcatili, S.

AU - Avigo, C.

AU - Sollini, M.

AU - Erba, P. A.

AU - Mariani, G.

PY - 2013/4

Y1 - 2013/4

N2 - Purpose: Nonuniform activity within the target lesions and the critical organs constitutes an important limitation for dosimetric estimates in patients treated with tumor-seeking radiopharmaceuticals. The tumor control probability and the normal tissue complication probability are affected by the distribution of the radionuclide in the treated organtissue. In this paper, a straightforward method for calculating the absorbed dose at the voxel level is described. This new method takes into account a nonuniform activity distribution in the targetorgan. Methods: The new method is based on the macroscopic S-values (i.e., the S-values calculated for the various organs, as defined in the MIRD approach), on the definition of the number of voxels, and on the raw-count 3D array, corrected for attenuation, scatter, and collimator resolution, in the lesionorgan considered. Starting from these parameters, the only mathematical operation required is to multiply the 3D array by a scalar value, thus avoiding all the complex operations involving the 3D arrays. Results: A comparison with the MIRD approach, fully described in the MIRD Pamphlet No. 17, using S-values at the voxel level, showed a good agreement between the two methods for 131I and for 90Y. Conclusions: Voxel dosimetry is becoming more and more important when performing therapy with tumor-seeking radiopharmaceuticals. The method presented here does not require calculating the S-values at the voxel level, and thus bypasses the mathematical problems linked to the convolution of 3D arrays and to the voxel size. In the paper, the results obtained with this new simplified method as well as the possibility of using it for other radionuclides commonly employed in therapy are discussed. The possibility of using the correct density value of the tissueorgans involved is also discussed.

AB - Purpose: Nonuniform activity within the target lesions and the critical organs constitutes an important limitation for dosimetric estimates in patients treated with tumor-seeking radiopharmaceuticals. The tumor control probability and the normal tissue complication probability are affected by the distribution of the radionuclide in the treated organtissue. In this paper, a straightforward method for calculating the absorbed dose at the voxel level is described. This new method takes into account a nonuniform activity distribution in the targetorgan. Methods: The new method is based on the macroscopic S-values (i.e., the S-values calculated for the various organs, as defined in the MIRD approach), on the definition of the number of voxels, and on the raw-count 3D array, corrected for attenuation, scatter, and collimator resolution, in the lesionorgan considered. Starting from these parameters, the only mathematical operation required is to multiply the 3D array by a scalar value, thus avoiding all the complex operations involving the 3D arrays. Results: A comparison with the MIRD approach, fully described in the MIRD Pamphlet No. 17, using S-values at the voxel level, showed a good agreement between the two methods for 131I and for 90Y. Conclusions: Voxel dosimetry is becoming more and more important when performing therapy with tumor-seeking radiopharmaceuticals. The method presented here does not require calculating the S-values at the voxel level, and thus bypasses the mathematical problems linked to the convolution of 3D arrays and to the voxel size. In the paper, the results obtained with this new simplified method as well as the possibility of using it for other radionuclides commonly employed in therapy are discussed. The possibility of using the correct density value of the tissueorgans involved is also discussed.

KW - 3D dosimetry

KW - internal dosimetry

KW - Nuclear Medicine Therapy

KW - voxel dosimetry

UR - http://www.scopus.com/inward/record.url?scp=84876181059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876181059&partnerID=8YFLogxK

U2 - 10.1118/1.4794473

DO - 10.1118/1.4794473

M3 - Article

C2 - 23556921

AN - SCOPUS:84876181059

VL - 40

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 4

M1 - 042505

ER -